Zenas BioPharma (ZBIO) Other financing activities (2024 - 2026)

Zenas BioPharma's Other financing activities history runs 3 years deep, the most recent figure standing at $6.4 million for Q1 2026.

• In Q1 2026, Other financing activities changed N/A year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $20.7 million (changed N/A YoY), while the FY2025 annual figure was $12.7 million, up 99.95% from the prior year.
• Other financing activities was $6.4 million for Q1 2026 at Zenas BioPharma, down from $9.3 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $9.3 million in Q4 2025 to a low of $439000.0 in Q3 2024.
• Historically, Other financing activities has averaged $3.7 million across 3 years, with a median of $2.6 million in 2024.
• Biggest YoY gain for Other financing activities was 108.83% in 2025; the steepest drop was 108.83% in 2025.
• A 3-year view of Other financing activities shows it stood at $4.5 million in 2024, then surged by 108.83% to $9.3 million in 2025, then tumbled by 31.48% to $6.4 million in 2026.
• The last three Other financing activities figures came in at $6.4 million (Q1 2026), $9.3 million (Q4 2025), and $4.5 million (Q4 2024), per Business Quant data.